# Saliva-based COVID-19 DNA Aptamer Test

> **NCT04974203** · NA · UNKNOWN · sponsor: **Achiko AG** · enrollment: 200 (estimated)

## Conditions studied

- Covid19

## Interventions

- **DEVICE:** AptameX

## Key facts

- **NCT ID:** NCT04974203
- **Lead sponsor:** Achiko AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07
- **Primary completion:** 2021-08
- **Final completion:** 2021-08
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2021-07-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04974203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04974203, "Saliva-based COVID-19 DNA Aptamer Test". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04974203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*